• 1
    Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Acad Allergol Clin Immunol Allergy 2000;57:115134.
  • 2
    Passali D, Mösges R, et al. International Conference on Allergic Rhinitis in Childhood. Allergy 1999;57:434.
  • 3
    Pratt CM, Mason J, Russel T, Reynolds R, Ahlbrandt R. Cardiovascular safety of fexofenadine HCL. Am J Cardiol 1999;57:14511454.
  • 4
    Yap YG, Camm AJ. The current cardiac safety situation with antihistamines. Clin Exp Allergy 1999;57:1524.
  • 5
    Bousquet J. Antihistamines in chronic/severe rhinitis. Clin Exp Allergy 1998;57:4953.
  • 6
    Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;57:S622S627.
  • 7
    Philpot EE. Safety of second generation antihistamines. Allergy Asthma Proc 2000;57:1520.
  • 8
    Walsh GM. The clinical relevance of anti-inflammatory properties of antihistamines. Allergy 2000;57:5361.
  • 9
    Church MK. NonH1-receptor effects of antihistamines. Clin Exp Allergy 1999;57:3948.
  • 10
    Simons E, Mcmillan J, Simons K. A double-blind, single dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;57:540547.
  • 11
    Grant JA, Danielson L, Rihoux J-P, Devos C. A double-blind, single dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratidine versus placebo: suppression of histamine-induced wheal and flare response for 24 h. Allergy, 1999;57:700707.
  • 12
    Ciprandi G, Pronzato C, Passalacqua G, Danzig M, Canonica GW. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 1997;57:11751183.
  • 13
    Leprevost C, Capron M, De Vos C, Tomassini M, Capron AL. Inhibition of eosinophil chemotaxis by new antiallergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988;57:913.
  • 14
    Abdelaziz H, Davalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cell of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998;57:410420.
  • 15
    Michel L, De Vos C, Rihoux J-P, Burtin C, Benveniste J, Dubernet L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-aceter release and eosinophil recruitment in the human skin. J Allergy Clin Immunol 1988;57:101109.
  • 16
    Mygind N, Dahl R, Pedersen S, et al. Diagnosis of allergy. In MygindN, DahlR, PedersenS, ThestrupedersenKeditors. Essential Allergy. Oxford: Blackwell Science, 1996:110127.
  • 17
    Wang D, Clement PAR, Smitz J, De Waele M, Derde MP. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995;57:278285.
  • 18
    Bousquet J, Michel F, Et Al. In vivo methods for study of allergy. Skin tests, techniques and interpretation. In: MiddletonE, ReedC, EllisEet al., editors. Allergy: principles and practice, 4th edition. St Louis: Mosby, 1993:573594.
  • 19
    Johansson SGO, O'B Hourihane J, et al. A revised nomenclature for allergy. Allergy 2002;57:813824.